Information and Suggestions of GYNEMED April 2023 Edition Download … read more ›
Today ISAR 2023 starts in Bhopal and we are happy to present our Gynemed MediaLine together with our partner Intermedics. We also wish our HT … read more ›
…and a happy and healthy new year from the team of Gynemed! … read more ›
Dear customers, we would like to inform you that we will be closed from December 24’th to 31’st for Christmas. We will be back for you … read more ›
Today starts the PTMRie Conference (The Polish Society of Reproductive Medicine and Embryology) and we thank our distributor KlimaPol for the presentation of Gynemed products … read more ›
Dear Friends, In this current issue we are especially pleased to be able to present to you a few impressions of this year‘s ESHRE after … read more ›
An expert round debriefing the clinical highlights from the ESHRE 2022. Live, concise, neutral and with a focus on clinical relevance! Saturday July 16th 9:00 … read more ›
We are looking forward to the ESHRE 38th Annual Meeting in Milan. Visit our Booth I-13! Meet the HTL group and check out our full … read more ›
Meet our partner MFC Global at our ESHRE booth (I-13) for a presentation and video demonstration of SpermVD. A novel solution for cryopreservation of small … read more ›
The HTL group IVF family came together for a wonderful sales and service training hosted by IVFtech ApS in Copenhagen, Denmark. HTL companies Planer Ltd, IVFtech ApS, Hamilton Thorne, Inc., … read more ›
Big News: We’re Growing!
Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics
product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.
✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service
We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.
Learn More About the Acquisition
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information